AureoGen Biosciences, Inc.

AureoGen is developing a novel, first in class drug for the treatment of systemic fungal infections, a $6 billion market with an immediate unmet medical need.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Kalamazoo, MI, US
  • Currency USD
  • Founded August 2003
  • Employees 2
  • Website aureogen.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free